TORL BioTherapeutics
Latest round
- Series B
Last raised
- Apr 2024
Total raised
- $158M
Investors
- 15
About TORL BioTherapeutics
Founded in 2018 and based in California, US, TORL BioTherapeutics, LLC is a clinical-stage biopharmaceutical firm focused on developing antibody-based therapeutics to help cancer patients. David Licata (CEO), Dennis Slamon, Mark Attanasio, and Neil O'Brien are the co-founders of the company. The company provides TORL-1-23, a CLDN6-directed ADC created for patients with a variety of cancer types.2 are two further clinical-stage programmes offered by the business. TORL is also developing preclinical ADCs (antibody-drug conjugates) and mAbs (monoclonal antibodies) for oncologic indications.
Who invested in TORL BioTherapeutics
15 investors across 2 rounds
See all investors in TORL BioTherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TORL BioTherapeutics
Who invested in TORL BioTherapeutics?
TORL BioTherapeutics has 15 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TORL BioTherapeutics raised?
TORL BioTherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did TORL BioTherapeutics last raise money?
TORL BioTherapeutics's most recent round on record is a Series B, in Apr 2024.
What does TORL BioTherapeutics do?
Founded in 2018 and based in California, US, TORL BioTherapeutics, LLC is a clinical-stage biopharmaceutical firm focused on developing antibody-based therapeutics to help cancer patients.
Where is TORL BioTherapeutics headquartered?
TORL BioTherapeutics is headquartered in Culver, US.
Which VCs invest in companies like TORL BioTherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TORL BioTherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like TORL BioTherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.